Solutions for Novel Coronavirus
BASF has a product included on the EPA “List N” as well as the CBC (Center for Biocide Chemistries) list of “Novel Coronavirus (COVID-19) – Fighting Products” for use during the COVID-19 pandemic.
This product is Aseptrol® S10-Tab (EPA Reg. No. 70060-19). BASF's distributor Quip Laboratories, Inc. (Quip Labs) distributes this product commercially as MB-10 Tablets (EPA Reg. No. 70060-19-46269). MB-10 Tablets (EPA Reg. No. 70060-19-46269) has demonstrated effectiveness against a similar virus to SARS-CoV-2 on hard, non-porous surfaces. Therefore, MB-10 Tablets (EPA Reg. No. 70060-19-46269) can be used against SARS-CoV-2 when used in accordance with the directions for use against Norovirus (Feline Calicivirus) and Porcine Circovirus on hard, non-porous surfaces. Refer to the CDC website for additional information
EPA Registration Number #70060-19
We know that SARS-CoV-2 is not the only concern facing hospitals and other clinical settings exposed to a variety of pathogenic organisms, which is why it’s critical that disinfectants, such as MB-10 Tablets, are efficacious against a broad spectrum of bacteria and viruses. When used as directed on hard, non-porous surfaces, MB-10 Tablets have demonstrated efficacy against these viruses:
- Ebola Virus
- Hepatitis B Virus
- Hepatitis C Virus
- Swine Influenza A Virus
- Avian Influenza A Virus
- Influenza A Virus
MB-10 Tablets have also demonstrated efficacy as a disinfecting agent on hard, non-porous surfaces against bacteria including Salmonella enterica, Helicobacter pylori (H. pylori), Escherichia coli (E. coli) O157:H7, and Staphylococcus aureus (ATCC 6538 and MRSA).
Please see the label for additional viruses and other pathogens.
MB-10 Tablets present a convenient method on the market for leveraging the benefits of chlorine dioxide in hygiene applications. The tablet form is fairly unique in this category, and makes MB-10 Tablets easy to use, easy to store, and easy to ship.
Multiple use sites
MB-10 Tablets have multiple use areas across a variety of settings, including:
- Health care facilities (hospitals and other clinical settings)
- Institutional and industrial facilities
- Veterinary facilities
- Laboratory and animal facilities
- Facilities where food contact surfaces require sanitization
Fighting forward, together
Our primary goal is to aid in the efforts to stop the spread of SARS-CoV-2 and focus on the health and safety of our global community.
We encourage anyone interested in learning more about how to fight this pandemic to refer to EPA List N and CBC list to become better informed on product options. For more information on MB-10 Tablets and how they can be used in your facility, visit the Quip Laboratories, Inc. website.
Important information about the EPA List N and CBC list
EPA List N and the CBC list are both important sources of information for disinfectants expected to be effective against SARS-CoV-2. The CBC list from the American Chemistry Council (ACC) includes products pre-approved by the EPA for use against emerging viral pathogens and/or have a Human Coronavirus claim. This list is not intended to be exhaustive and, while the CBC has made efforts to ensure the information on the list is accurate and products included are suitable for use during the COVID-19 outbreak, the CBC cannot make a formal determination of the effectiveness of a product in fighting pathogens like COVID-19.
Products on the EPA List N are expected to be effective against SARS-CoV-2 because they have:
- “Demonstrated efficacy against a harder-to-kill virus;
- Qualified for the emerging viral pathogens claim; or
- Demonstrated efficacy against another human coronavirus similar to SARS CoV-2.”
While this is stringent criteria, as with the CBC list, products on the EPA List N have not yet been specifically tested against SARS-CoV-2. The EPA notes: “SARS-CoV-2 is a new virus. Such pathogens are often unavailable commercially for laboratory testing.”
When purchasing a product with the intention of combatting the SARS-CoV-2 outbreak, check the product to see if its EPA registration number is on List N. “If it is, you have a match and the product can be used against SARS-CoV-2,” the EPA says on its website.